Compound details
Cheiranthoside IV
| Compound ID | CDAMM00559 |
|---|---|
| Common name | Cheiranthoside IV | IUPAC name | [6-[[10-formyl-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-2-methyl-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-4-yl] acetate |
| Molecular formula | C37H54O14 |
| Retention time | 3.66 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 723.354 | Theoretical mz | 723.358 |
| Error | 6.6 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.0007 |
| Inchi key | JPDBUGXWRYMUSG-WQRLSDMFNA-N |
|---|---|
| Smiles | O=CC12CCC(OC3OC(C)C(OC4OC(C)C(O)C(O)C4O)C(OC(=O)C)C3)CC2(O)CCC5C1CCC6(C)C(C7=CC(=O)OC7)CCC56O |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T40800 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P05023 | ATP1A1 |
| T40800 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P05023 | ATP1A1 |
| T40800 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P05023 | ATP1A1 |
| T40800 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P05023 | ATP1A1 |
| T40800 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P05023 | ATP1A1 |
| T40800 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P05023 | ATP1A1 |
| T40800 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P05023 | ATP1A1 |